FDC Ltd, a drug company from Mumbai, has had to recall more than 60,000 bottles of Timolol Maleate Ophthalmic Solution USP across the US. The trouble started when they found out the bottles were faulty the cap’s spike was getting jammed in the noz...
According to Health Ministry officials, there are about 10,000 medium and small manufacturing businesses and only 100 of them submitted applications.
Cell line development expert ProBioGen has declared the partnership with biotech firm Polpharma Biologics to deliver cell line for one of the biosimilar molecules being developed by Polpharma...
Indian pharmaceutical companies may encounter significant hurdles in the US following President Donald Trump’s new executive orders aimed at promoting domestic drug production...
Ashok Kumar, President, Centre for Research and Development at Ipca Laboratories Limited, engages in an exclusive interaction with India Pharma Outlook, wherein he discussed how green chemistry is revolutionizing API production in India. In order to
Indian Contract Development and Manufacturing Organisations (CDMOs) like Suven Pharmaceuticals, Syngene International, Laurus Labs, and Divi’s Laboratories are witnessing a surge in demand as global pharma players seek to reduce dependence on...
The U.S. Food & Drug Administration has approved Celecoxib capsules to market.
The Managing Director and Chairperson of BDR Pharmaceutical, Dharmesh Shah, stated that they are planning to expand their manufacturing buyouts with the US investment of $100 million.
Gland Pharma Limited based in Hyderabad received approval from the United States Food and Drug Administration (USFDA) to develop its Abbreviated New Drug Application (ANDA) for Latanoprostene Bunod Ophthalmic Solution, 0.024% at its facilities...
Zydus Lifesciences Ltd has received final approval from the United States Food and Drug Administration (USFDA) to manufacture and market the generic version of Niacin extended-release tablets, a cholesterol-lowering medication...